Back to Search

DIANE HERSHOCK, MD

MD

Hematology & Oncology Physician

NPI: 1770652158IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology (Internal Medicine) Physician

Internal Medicine — Hematology

Code: 207RH0000X

MD057563L(PA)
Medical Oncology Physician

Internal Medicine — Medical Oncology

Code: 207RX0202X

MD057563L(PA)
Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

MD057563L(PA)

CMS Specialties

PrimaryHEMATOLOGY/ONCOLOGY

Education

JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY

Class of 1993

Research & Publications (12)

Genetics, prevention and screening for melanoma.
PMID 16110635·Cancer Chemother Biol Response Modif·2005
6-review
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
PMID 17960013·N Engl J Med·2007
3-trial
A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer.
PMID 17932893·Cancer·2007
3-trial
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
PMID 17716826·Int J Radiat Oncol Biol Phys·2007
2-rct
Preliminary investigation of symptom distress in the head and neck patient population: validation of a measurement instrument.
PMID 16601435·Am J Clin Oncol·2006
4-observational
Esophagectomy and splenectomy in a patient with osteopetrosis.
PMID 15942603·J Thorac Cardiovasc Surg·2005
5-case
Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer.
PMID 15577438·Am J Clin Oncol·2004
3-trial
Merkel cell carcinoma.
PMID 15115648·Curr Treat Options Oncol·2004
6-review
Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
PMID 15093901·Int J Radiat Oncol Biol Phys·2004
8-other
Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial.
PMID 12351593·J Clin Oncol·2002
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1600 ST LUKES BLVD
EASTON, PA 18045

Quick Facts

NPI
1770652158
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
3
Locations
1
Years in Practice
33
Publications
12

Are you this provider?

Claim Your Profile